CapForce Inc.
CFOR- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001293818
No open-market purchases or sales by CapForce Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding CapForce Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 25 | 23 | −2 |
| Shares | 3.45M | 8.79M | +5.33M (+154.4%) |
| Value | $1.88M | $2.52M | +$633.0K (+33.6%) |
New holders (2)
Institutions that held CapForce Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 5,300,000 | $1.52M | 0.04% |
| Jane Street Group, LLC | 19,813 | $6.00K | 0.00% |
Sold out (4)
Institutions that held CapForce Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 120,964 | $66.0K |
| Millennium Management LLC | 24,234 | $13.0K |
| Huntington National Bank | 42 | $0 |
| Geneos Wealth Management Inc. | 1,500 | $0 |